2026-07-28T16:52:37Zhttps://docta.ucm.es/rest/oai/requestoai:docta.ucm.es:20.500.14352/76362024-04-16T16:45:30Zcom_20.500.14352_14col_20.500.14352_15
Docta Complutense
author
Gisbert Garzarán, Miguel
author
Lozano Borregón, Daniel
author
Vallet Regí, María Dulce Nombre
2023-06-17T08:56:43Z
2023-06-17T08:56:43Z
2020-12-18
1999-4923
10.3390/ijms21249696
https://hdl.handle.net/20.500.14352/7636
https://doi.org/10.3390/ijms21249696
https://www.ucm.es/valletregigrouphttps://www.mdpi.com/1422-0067/21/24/9696
Current chemotherapy treatments lack of great selectivity towards tumoral cells, which 13 leads to nonspecific drug distribution and subsequent side effects. In this regard, the use of 14 nanoparticles able to encapsulate and release therapeutic agents has attracted growing attention. In 15 this sense, mesoporous silica nanoparticles (MSNs) have been widely employed as drug carriers 16 owing to their exquisite physico-chemical properties. Because MSNs present a surface full of silanol 17 groups, they can be easily functionalized to endow the nanoparticles with many different 18 functionalities, including the introduction of moieties with affinity for the cell membrane or relevant 19 compartments within the cell, thus increasing the efficacy of the treatments. This review manuscript 20 will provide the state-of-the-art on MSNs functionalized for targeting subcellular compartments, 21 focusing on the cytoplasm, the mitochondria and the nucleus.
eng
Atribución 3.0 España
Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles.
journal article
URL
https://docta.ucm.es/bitstreams/bbc6e890-6073-4f36-aad4-3b0b9d6208e0/download
File
MD5
5ba0124370c3c60b23d8bfc8ac371e0e
2609793
application/pdf
ijms-21-09696-v2.pdf